newsfilter
← Latest News
GlobeNewswire·

Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys

Royalty Pharma to provide tailored funding solution to enable MorphoSys' acquisition of Constellation Pharmaceuticals Investment is anchored by royalties on Janssen's Tremfya Partnership also includes royalties on four development-stage therapies, Dev